Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2000
09/21/2000WO2000054731A2 Syndesmos and uses thereof
09/21/2000WO2000054651A2 Human tumor necrosis factor receptor-like genes
09/21/2000WO2000054583A1 Methods for culturing fluid-filled sensory organs
09/21/2000WO2000043043B1 Ligand-peg post-coating stabilized lipoplex and polyplex for targeted gene delivery
09/21/2000WO2000040711A3 Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon
09/21/2000WO2000039303A3 Modified hiv env polypeptides
09/21/2000WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use
09/21/2000WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000WO2000022095A3 Method and apparatus for direct in vivo gene transfer by electrotransfection
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000DE19912502A1 Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung Nanoscale particles, complexes with polynucleotides and their use
09/21/2000DE19910108A1 Zellen, die ein Amyloidvorläuferprotein und eine alpha-Sekretase coexprimieren, ein Testverfahren zur Identifikation alpha-Sekretase-aktiver Substanzen sowie eines zur Identifikation weiterer Sekretasen, ein Testverfahren zur Bestimmung der Anfälligkeit gegenüber Morbus Alzheimer und Verwendung von Nukleinsäuren, die für eine alpha-Sekretase codieren, für die Gentherapie Cells, which co-express an amyloid precursor protein and an alpha-secretase, a test method for identifying alpha-secretase active substances as well as one further for identifying secretases, a test method for determining the susceptibility to Alzheimer's disease, and use of nucleic acids encoding an alpha-secretase , for gene therapy
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367906A1 Tcl-1b gene and protein and related methods and compositions
09/21/2000CA2367375A1 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2366054A1 Lentiviral vector system for high quantity screening
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000CA2365451A1 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364650A1 50 human secreted proteins
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364549A1 50 human secreted proteins
09/21/2000CA2363496A1 Differential expression of organellar gene products
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2361277A1 49 human secreted proteins
09/20/2000EP1036844A1 Examination method, examination reagent and remedy for diseases caused by variation in lkb1 gene
09/20/2000EP1036188A1 ribG
09/20/2000EP1036182A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
09/20/2000EP1036180A2 Circovirus sequences related to piglet weight loss disease (pwd)
09/20/2000EP1036177A1 Novel vectors and genes exhibiting increased expression
09/20/2000EP1036174A2 Novel peptide, apoep1.b, compositions and uses thereof
09/20/2000EP1036169A1 Nucleic acid mediated rna tagging and rna revision
09/20/2000EP1036167A2 Nuclear targeting by means of streptococcal protein h
09/20/2000EP1036165A1 Human rnase h and compositions and uses thereof
09/20/2000EP1036163A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
09/20/2000EP1036162A1 Engraftable neural progenitor and stem cells for brain tumor therapy
09/20/2000EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy
09/20/2000EP1035870A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
09/20/2000EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/20/2000EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
09/20/2000EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
09/20/2000CN1267331A Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
09/20/2000CN1267307A Interleukin-18 binding proteins, their preparation and use
09/20/2000CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b
09/20/2000CN1267223A Carcinostatic agents
09/20/2000CN1056617C Melanoma-inhibiting protein
09/19/2000US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121247 Locally administering to patient preparation comprising dna expression construct comprising human gamma-interferon coding sequence
09/19/2000US6121246 Method for treating ischemic tissue
09/19/2000US6121047 Antisense modulation of SHP-1 expression
09/19/2000US6121046 Synthetic antisense oligodeoxynucleotides targeted to human ache
09/19/2000US6121028 MurE
09/19/2000US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases
09/19/2000US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners
09/19/2000US6121000 Nucleotide sequences; antimetastatis agents; for inhibiting growth of chemotherapy resistant tumors and increasing sensitivity of tumors to chemotherapy
09/19/2000US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same
09/19/2000US6120798 Liposome-entrapped polynucleotide composition and method
09/19/2000US6120794 Emulsion and micellar formulations for the delivery of biologically active substances to cells
09/19/2000US6120771 Isolated polypeptide; diagnosis, therapy
09/19/2000US6120763 Compositions and methods for enhanced tumor cell immunity in vivo
09/19/2000CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed
09/17/2000CA2300782A1 Modified factor viii cdna
09/14/2000WO2000053808A1 Beclin and uses thereof
09/14/2000WO2000053795A1 Adipose-derived stem cells and lattices
09/14/2000WO2000053786A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000WO2000053785A2 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins
09/14/2000WO2000053779A1 Translation regulation system and methods for use thereof
09/14/2000WO2000053776A2 Human kallikrein-like genes
09/14/2000WO2000053775A2 Prevention and treatment of viral infections
09/14/2000WO2000053773A2 Methods for mitochondrial gene therapy
09/14/2000WO2000053750A1 Compositions and methods for the treatment of tumors
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
09/14/2000WO2000053745A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053730A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053218A1 Neurodegenerative disorder related gene
09/14/2000WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000WO2000053210A1 Methods of treatment and prevention of restenosis
09/14/2000WO2000053163A1 Bacterial ghosts as carrier and targeting vehicles
09/14/2000WO2000053019A1 Dna vaccination for treatment of autoimmune disease
09/14/2000WO2000038737A3 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
09/14/2000WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression
09/14/2000WO2000037609A3 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/14/2000WO2000036909A3 In vivo odontogenic model using rodent's mandibular incisor
09/14/2000WO2000034496A3 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
09/14/2000WO2000031263A3 Gtpase associated proteins
1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 870